Skip to footer

Next-gen pharmacovigilance: Key digital transformation drivers

Dr. Alejandra Guerchicoff

Industry Leader, TCS ADD Safety

Highlights

  • The life sciences industry faces a pressing need to digitally transform the safety surveillance process to facilitate next-generation pharmacovigilance (PV).
  • The PV paradigm is evolving, and to handle the imminent data deluge, the industry needs to invest in novel and advanced PV platforms that enable the processing and analysis of data in real-time to bring safe products to patients in need, and on time.
  • A cloud-first strategy will soon become a business imperative for organizations to scale and adapt to the fast-changing regulatory environment.
  • Strategic and visionary industry leadership emphasizes the adoption of advanced digital technologies to help people succeed in their roles, and to retain and upskill team members by transforming manual tasks into high-value jobs.